Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$31.71 - $43.0 $63,832 - $86,559
-2,013 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$29.88 - $37.04 $926 - $1,148
-31 Reduced 1.52%
2,013 $74.6 Million
Q4 2021

Jan 14, 2022

SELL
$25.61 - $35.1 $614 - $842
-24 Reduced 1.16%
2,044 $62.2 Million
Q3 2021

Oct 12, 2021

BUY
$33.54 - $40.55 $69,360 - $83,857
2,068 New
2,068 $69,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Koshinski Asset Management, Inc. Portfolio

Follow Koshinski Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.